When did Relay Therapeutics, Inc. report Q4 2024 earnings?

Relay Therapeutics, Inc. (RLAY) reported Q4 2024 earnings on February 26, 2025 after market close.

What were Relay Therapeutics, Inc.'s Q4 2024 revenue and EPS?

Relay Therapeutics, Inc. reported revenue of - and eps of $-0.45 for Q4 2024.

Did Relay Therapeutics, Inc. beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.57 by $0.12.

Where can I find Relay Therapeutics, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-027756) directly on SEC EDGAR. The filing index links above go to sec.gov.

Relay Therapeutics, Inc. RLAY Q4 2024 Annual earnings

Reported February 26, 2025 · After market close

Revenue-

EPS-$0.45Beat by $0.12

EPS estimate-$0.57

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$960.0K

EPS estimate-$0.41

Financials

Q4 2024

Income statement

See full

Revenue-—

Operating income-$85.0M+7.8%

Net income-$76.0M+9.0%

EPS (diluted)-$0.42+37.3%

Balance sheet

See full

Cash & equivalents$124.3M-13.5%

Total debt$48.5M-9.3%

Total equity$777.8M+3.4%

Total assets$871.3M+3.2%

Cash flow

See full

Operating cash flow-$57.9M+35.1%

CapEx--100%

Free cash flow-$57.9M+35.2%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$689.62M-48.9%

Enterprise value$613.83M-51.3%

P/S68.9×+16.1×

Profitability

See full

Operating margin-3,722.1%-10,498pp

Net margin-3,374.7%-9,851pp

FCF margin-2,509.5%-26,224pp

Returns & leverage

See full

Return on equity-44.2%+4.8pp

Debt / equity0.1×0.0×

Current ratio16×-9.5×

Versus estimates

Revenue

Q1 2026$3.0MMiss by $2.6M Q4 2025$7.0MBeat by $2.0M Q2 2025$677.0KBeat by $662.7K Q1 2025$7.7MBeat by $3.9M

Diluted EPS

Q1 2026-$0.41Miss by $0.06 Q4 2025-$0.32Beat by $0.06 Q3 2025-$0.43Miss by $0.04 Q2 2025-$0.41Beat by $0.08 Q1 2025-$0.46Beat by $0.04

Q4 2024-$0.45Beat by $0.12

Ask the moment Relay Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Relay Therapeutics, Inc. report Q4 2024 earnings?: Relay Therapeutics, Inc. (RLAY) reported Q4 2024 earnings on February 26, 2025 after market close.
What were Relay Therapeutics, Inc.'s Q4 2024 revenue and EPS?: Relay Therapeutics, Inc. reported revenue of - and eps of $-0.45 for Q4 2024.
Did Relay Therapeutics, Inc. beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.57 by $0.12.
Where can I find Relay Therapeutics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-027756) directly on SEC EDGAR. The filing index links above go to sec.gov.